We are proud to celebrate the success of SCALE 2025, Veranova’s flagship symposium held on July 24 at the Boston Marriott in Cambridge, MA.
Bringing together over 100 attendees from across the pharmaceutical and biotech industries, SCALE (science, collaboration, acceleration, launch and execution) offered a unique platform to explore the future of pharmaceutical development through meaningful dialogue, cutting-edge science, and cross-sector collaboration.
An Inspiring Day of Discovery and Connection
The day kicked off with a welcome note from Rohtash Kumar, Veranova’s SVP & CTO, followed by an opening address from Veranova’s CEO, Mike Riley, setting the tone for a day dedicated to advancing therapeutic innovation.
Highlights of the symposium include a keynote presentation from Nobel Laureate Carolyn Bertozzi, Professor of Chemistry at Stanford University, who shared groundbreaking insights into bio-orthogonal chemistry and its journey from bench to bedside, and an inspiring session on novel oligonucleotide synthesis delivered by Marvin Caruthers, Distinguished Professor from the University of Colorado Boulder.
During the afternoon, Brad Pentelute, Professor from the Massachusetts Institute of Technology (MIT), delivered a thought-provoking talk discussing on-demand macromolecule manufacturing with AI and robots.
Throughout the day, attendees engaged with a full agenda of expert presentations, panel discussions, and poster sessions covering topics such as:
We’d like to thank all our guest speakers, panelists, and attendees for contributing to an unforgettable event. Whether exploring sustainability, scaling complex processes, or embracing new technologies, the discussions at SCALE 2025 reaffirmed the importance of working together to advance the next generation of therapeutics.
Take a look at the gallery below for highlights from SCALE 2025!
Discover new ways to advance your science with Veranova.
Contact us